Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-11-26

Clinical Trial Update: Phase I/II Trial of a Malaria Vaccine in Adults Living in the United States of America [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial of a malaria vaccine conducted in adults in the United States has been completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: U.S. Army Medical Research and Development Command | Conditions: Plasmodium Falciparum Malaria | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2018-11-26